Stephen C. Benoit
Amministratore Delegato presso Metabolic Solutions Development Co. LLC
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Rolf Kletzien | M | - |
Metabolic Solutions Development Co. LLC
 Metabolic Solutions Development Co. LLC Pharmaceuticals: GenericHealth Technology Metabolic Solutions Development Co. LLC operates as a drug discovery and development company. It develops novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company was founded by Jerry Colca and Rolf Kletzien in 2006 and is headquartered in Kalamazoo, MI. | 18 anni |
| Jerry Colca | M | - |
Metabolic Solutions Development Co. LLC
Metabolic Solutions Development Co. LLC Pharmaceuticals: GenericHealth Technology Metabolic Solutions Development Co. LLC operates as a drug discovery and development company. It develops novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company was founded by Jerry Colca and Rolf Kletzien in 2006 and is headquartered in Kalamazoo, MI. | 18 anni |
| Jerry Callahan | M | - |
Metabolic Solutions Development Co. LLC
Metabolic Solutions Development Co. LLC Pharmaceuticals: GenericHealth Technology Metabolic Solutions Development Co. LLC operates as a drug discovery and development company. It develops novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company was founded by Jerry Colca and Rolf Kletzien in 2006 and is headquartered in Kalamazoo, MI. | 17 anni |
| Daniel Lawrence | M | - |
MDI Therapeutics, Inc.
 MDI Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology MDI Therapeutics, Inc. engages in pharmaceuticals company. It focuses on developing small molecule PAI-1 inhibitors for the treatment of fibrosis. The company was founded by Daniel A. Lawrence in 2015 and is headquartered in Novi, MI. | 9 anni |
| Angeline K. Shashlo | F | - |
Metabolic Solutions Development Co. LLC
Metabolic Solutions Development Co. LLC Pharmaceuticals: GenericHealth Technology Metabolic Solutions Development Co. LLC operates as a drug discovery and development company. It develops novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company was founded by Jerry Colca and Rolf Kletzien in 2006 and is headquartered in Kalamazoo, MI. | 15 anni |
| Danny Mack Mitchell | M | 95 |
Alpha Sigma Nu
| - |
| William Parfet | M | 77 |
Metabolic Solutions Development Co. LLC
Metabolic Solutions Development Co. LLC Pharmaceuticals: GenericHealth Technology Metabolic Solutions Development Co. LLC operates as a drug discovery and development company. It develops novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company was founded by Jerry Colca and Rolf Kletzien in 2006 and is headquartered in Kalamazoo, MI. | - |
| Mike J. Jandernoa | M | 73 |
Metabolic Solutions Development Co. LLC
Metabolic Solutions Development Co. LLC Pharmaceuticals: GenericHealth Technology Metabolic Solutions Development Co. LLC operates as a drug discovery and development company. It develops novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company was founded by Jerry Colca and Rolf Kletzien in 2006 and is headquartered in Kalamazoo, MI. | - |
| Mark Olesnavage | M | 71 |
Metabolic Solutions Development Co. LLC
Metabolic Solutions Development Co. LLC Pharmaceuticals: GenericHealth Technology Metabolic Solutions Development Co. LLC operates as a drug discovery and development company. It develops novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company was founded by Jerry Colca and Rolf Kletzien in 2006 and is headquartered in Kalamazoo, MI. | - |
| Melanie Cibik | F | 64 |
Alpha Sigma Nu
| - |
| Barclay P. Butler | M | - |
Alpha Sigma Nu
| - |
| James T. VanderLugt | M | - |
Metabolic Solutions Development Co. LLC
Metabolic Solutions Development Co. LLC Pharmaceuticals: GenericHealth Technology Metabolic Solutions Development Co. LLC operates as a drug discovery and development company. It develops novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company was founded by Jerry Colca and Rolf Kletzien in 2006 and is headquartered in Kalamazoo, MI. | - |
| Philip Masterson | M | - |
Alpha Sigma Nu
| - |
| Duane Day | M | - |
MDI Therapeutics, Inc.
MDI Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology MDI Therapeutics, Inc. engages in pharmaceuticals company. It focuses on developing small molecule PAI-1 inhibitors for the treatment of fibrosis. The company was founded by Daniel A. Lawrence in 2015 and is headquartered in Novi, MI. | - |
| Charles Burant | M | - |
Metabolic Solutions Development Co. LLC
Metabolic Solutions Development Co. LLC Pharmaceuticals: GenericHealth Technology Metabolic Solutions Development Co. LLC operates as a drug discovery and development company. It develops novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company was founded by Jerry Colca and Rolf Kletzien in 2006 and is headquartered in Kalamazoo, MI. | - |
Grafico relazionale
Relazione in diverse aziende
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 15 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Stephen C. Benoit
- Contatti personali
